In the current study, the data‐driven approach to differentiating the status of new‐onset diabetes in the Chinese community was reproducible, and the distribution of patients was similar, but not identical, to that of the study by Ahlqvist et al. We first reported the MIDD subgroup, which had a low risk burden equivalent to prediabetes, but with reduced insulin secretion. The gene discussed is INS; the disease is Onset.